<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="and detoxification by Chinese medicine [33]. Clinical trials have demonstrated" exact="Chloroquine" post="was proved to be effective in the control and"/>
 <result pre="associated with shorter time-to-viral-clearance (median 4 versus 11â€‰days, Pâ€‰ 44]." exact="Chloroquine" post="and Hydroxychloroquine Chloroquine (CQ) is a drug that widely"/>
 <result pre="shorter time-to-viral-clearance (median 4 versus 11â€‰days, Pâ€‰ 44]. Chloroquine and" exact="Hydroxychloroquine" post="Chloroquine (CQ) is a drug that widely used against"/>
 <result pre="time-to-viral-clearance (median 4 versus 11â€‰days, Pâ€‰ 44]. Chloroquine and Hydroxychloroquine" exact="Chloroquine" post="(CQ) is a drug that widely used against malaria"/>
 <result pre="drug has an antiviral potential [46]. The function mechanism of" exact="Chloroquine" post="is increasing the endosomal pH. With a pH higher"/>
 <result pre="receptors of sars-cov-2 which bind to their targets [47]. Therefore," exact="Chloroquine" post="can inhibit a pre-entry step of the viral cycle"/>
 <result pre="out by a Chinese researchers group about the efficiency of" exact="chloroquine" post="in in-vitro studies, using Vero E6 cells infected by"/>
 <result pre="by SARS-CoV-2 at a multiplicity of infection (MOI) of 0.05," exact="Chloroquine" post="was highly effective in decreasing viral replication and it"/>
 <result pre="concentration (CC50) larger than 100â€‰Î¼M) [49]. Another article indicated that" exact="Chloroquine" post="can inhibit in-vitro replication of HCoV-229E in epithelial lung"/>
 <result pre="effective against Middle East respiratory syndrome coronavirus (MERS-CoV) in-vitro [52]." exact="Hydroxychloroquine" post="(HCQ) with a very similar chemical structure to Chloroquine"/>
 <result pre="[52]. Hydroxychloroquine (HCQ) with a very similar chemical structure to" exact="Chloroquine" post="is one of the disease-modifying antirheumatic drugs that use"/>
 <result pre="capacity which prevents inflammation flare-ups and organ damage [53]. Both" exact="Chloroquine" post="and Hydroxychloroquine can raise the intracellular pH and inhibit"/>
 <result pre="prevents inflammation flare-ups and organ damage [53]. Both Chloroquine and" exact="Hydroxychloroquine" post="can raise the intracellular pH and inhibit the fusion"/>
 <result pre="antiviral outcomes [54]. In one case, the pharmacological activity of" exact="chloroquine" post="and hydroxychloroquine was checked out, the Vero cells were"/>
 <result pre="[54]. In one case, the pharmacological activity of chloroquine and" exact="hydroxychloroquine" post="was checked out, the Vero cells were infected with"/>
 <result pre="checked out, the Vero cells were infected with SARS-CoV-2 and" exact="Hydroxychloroquine" post="(EC50â€‰=â€‰0.72â€‰Î¼M) was found to be more potent than chloroquine"/>
 <result pre="and Hydroxychloroquine (EC50â€‰=â€‰0.72â€‰Î¼M) was found to be more potent than" exact="chloroquine" post="(EC50â€‰=â€‰5.47â€‰Î¼M) in-vitro because of smaller EC value [55]. On"/>
 <result pre="â€˜We have concluded that there is no beneficial effect of" exact="hydroxychloroquine" post="in patients hospitalized with COVID-19. We have therefore decided"/>
 <result pre="We have therefore decided to stop enrolling participants to the" exact="hydroxychloroquine" post="arm of the RECOVERY Trial with immediate effect. We"/>
 <result pre="public health. â€˜A total of 1542 patients were randomized to" exact="Hydroxychloroquine" post="and compared with 3132 patients randomized to usual care"/>
 <result pre="significant difference in the primary endpoint of 28-day mortality (25.7%" exact="Hydroxychloroquine" post="vs. 23.5% usual care; hazard ratio 1.11 [95% confidence"/>
 <result pre="available as soon as possible [56]. Remdesivir Remdesivir is an" exact="adenosine" post="nucleotide analog that is similar to tenofovir alafenamide -"/>
 <result pre="Remdesivir is an adenosine nucleotide analog that is similar to" exact="tenofovir alafenamide" post="- a nucleotide analog of adenosine 5-monophosphate - with"/>
 <result pre="is similar to tenofovir alafenamide - a nucleotide analog of" exact="adenosine" post="5-monophosphate - with antiviral activity against hepatitis B virus,"/>
 <result pre="analysis from the oropharyngeal swab was negative for SARS-CoV-2 [59]." exact="Ribavirin" post="Ribavirin is a nucleotides derivative competing with physiological nucleotide"/>
 <result pre="from the oropharyngeal swab was negative for SARS-CoV-2 [59]. Ribavirin" exact="Ribavirin" post="is a nucleotides derivative competing with physiological nucleotide for"/>
 <result pre="[60, 61]. Through the outbreak of SARS in Hong Kong," exact="ribavirin" post="was widely used for patients with or without the"/>
 <result pre="simultaneous use of steroids [62]. The EC50 against COVID-19 for" exact="Ribavirin" post="determined at 109.5â€‰Î¼M [63]. Based on previous studies about"/>
 <result pre="on previous studies about SARS and MERS, the combination of" exact="ribavirin" post="and IFN-Î², decreases the viral replication and disease severity"/>
 <result pre="models [64]. Due to unfavorable reactions, the proper dose of" exact="ribavirin" post="in the clinical application should be given carefully. Losartan"/>
 <result pre="in December 2019. Angiotensin receptor blockers (i.e., AT1R), like losartan," exact="olmesartan" post="and valsartan can inhibit Ang II-mediated vasoconstriction. Besides, aldosterone"/>
 <result pre="2019. Angiotensin receptor blockers (i.e., AT1R), like losartan, olmesartan and" exact="valsartan" post="can inhibit Ang II-mediated vasoconstriction. Besides, aldosterone inhibitors (e.g.,"/>
 <result pre="lopinavir, and interferon to non-ICU patients and the addition of" exact="methylprednisolone" post="to the above treatment for ICU patients resulted in"/>
 <result pre="the previous coronavirus such as SARS-CoV infections [72]. Lopinavir â€&quot;" exact="Ritonavir" post="Three anti-HIV drugs, ritonavir, lopinavir, and darunavir, might have"/>
 <result pre="2019 (COVID-19). It is implied that the therapeutic effect of" exact="ritonavir" post="and lopinavir on COVID-19 may be largely due to"/>
 <result pre="It is implied that the therapeutic effect of ritonavir and" exact="lopinavir" post="on COVID-19 may be largely due to their inhibitory"/>
 <result pre="to their inhibitory impact on CEP_C30 (coronavirus endopeptidase C30), while" exact="ritonavir" post="may have greater ability; the inhibitory impact of darunavir"/>
 <result pre="(CYP3A) isoenzyme in the liver. It is always used with" exact="ritonavir" post="to reduce the dose of lopinavir and enhance the"/>
 <result pre="is always used with ritonavir to reduce the dose of" exact="lopinavir" post="and enhance the plasma levels of lopinavir as ritonavir"/>
 <result pre="the dose of lopinavir and enhance the plasma levels of" exact="lopinavir" post="as ritonavir inhibits CYP3A isoenzyme. Lopinavir and ritonavir are"/>
 <result pre="of lopinavir and enhance the plasma levels of lopinavir as" exact="ritonavir" post="inhibits CYP3A isoenzyme. Lopinavir and ritonavir are antiretroviral protease"/>
 <result pre="levels of lopinavir as ritonavir inhibits CYP3A isoenzyme. Lopinavir and" exact="ritonavir" post="are antiretroviral protease inhibitors used in combination as a"/>
 <result pre="studies Table 5 Interaction between drugs [87] Therapy Specific interaction" exact="Ribavirin" post="-Anticoagulants Warfarin Lopinavir/Ritonavir -Anticoagulants Apixaban Rivaroxaban -Antiplatelets Clopidogrel Ticagrelor"/>
 <result pre="5 Interaction between drugs [87] Therapy Specific interaction Ribavirin -Anticoagulants" exact="Warfarin" post="Lopinavir/Ritonavir -Anticoagulants Apixaban Rivaroxaban -Antiplatelets Clopidogrel Ticagrelor -Statin Atorvastatin"/>
 <result pre="drugs [87] Therapy Specific interaction Ribavirin -Anticoagulants Warfarin Lopinavir/Ritonavir -Anticoagulants" exact="Apixaban" post="Rivaroxaban -Antiplatelets Clopidogrel Ticagrelor -Statin Atorvastatin Rosuvastatin Lovastatin Simvastatin"/>
 <result pre="[87] Therapy Specific interaction Ribavirin -Anticoagulants Warfarin Lopinavir/Ritonavir -Anticoagulants Apixaban" exact="Rivaroxaban" post="-Antiplatelets Clopidogrel Ticagrelor -Statin Atorvastatin Rosuvastatin Lovastatin Simvastatin -Antiarrhythmics"/>
 <result pre="Specific interaction Ribavirin -Anticoagulants Warfarin Lopinavir/Ritonavir -Anticoagulants Apixaban Rivaroxaban -Antiplatelets" exact="Clopidogrel" post="Ticagrelor -Statin Atorvastatin Rosuvastatin Lovastatin Simvastatin -Antiarrhythmics QT-prolonging medication"/>
 <result pre="interaction Ribavirin -Anticoagulants Warfarin Lopinavir/Ritonavir -Anticoagulants Apixaban Rivaroxaban -Antiplatelets Clopidogrel" exact="Ticagrelor" post="-Statin Atorvastatin Rosuvastatin Lovastatin Simvastatin -Antiarrhythmics QT-prolonging medication Digoxin"/>
 <result pre="Lopinavir/Ritonavir -Anticoagulants Apixaban Rivaroxaban -Antiplatelets Clopidogrel Ticagrelor -Statin Atorvastatin Rosuvastatin" exact="Lovastatin" post="Simvastatin -Antiarrhythmics QT-prolonging medication Digoxin Chloroquine/Hydroxychloroquine -Beta-blockers Metoprolol, carvedilol,"/>
 <result pre="-Anticoagulants Apixaban Rivaroxaban -Antiplatelets Clopidogrel Ticagrelor -Statin Atorvastatin Rosuvastatin Lovastatin" exact="Simvastatin" post="-Antiarrhythmics QT-prolonging medication Digoxin Chloroquine/Hydroxychloroquine -Beta-blockers Metoprolol, carvedilol, propranolol,"/>
 <result pre="Clopidogrel Ticagrelor -Statin Atorvastatin Rosuvastatin Lovastatin Simvastatin -Antiarrhythmics QT-prolonging medication" exact="Digoxin" post="Chloroquine/Hydroxychloroquine -Beta-blockers Metoprolol, carvedilol, propranolol, labetalol -Antiarrhythmics QT-prolonging agents"/>
 <result pre="Simvastatin -Antiarrhythmics QT-prolonging medication Digoxin Chloroquine/Hydroxychloroquine -Beta-blockers Metoprolol, carvedilol, propranolol," exact="labetalol" post="-Antiarrhythmics QT-prolonging agents Digoxin Additionally, itâ€™s noted that Hydroxychloroquine"/>
 <result pre="Digoxin Chloroquine/Hydroxychloroquine -Beta-blockers Metoprolol, carvedilol, propranolol, labetalol -Antiarrhythmics QT-prolonging agents" exact="Digoxin" post="Additionally, itâ€™s noted that Hydroxychloroquine consumption is better than"/>
 <result pre="propranolol, labetalol -Antiarrhythmics QT-prolonging agents Digoxin Additionally, itâ€™s noted that" exact="Hydroxychloroquine" post="consumption is better than chloroquine (during long-term use) due"/>
 <result pre="Digoxin Additionally, itâ€™s noted that Hydroxychloroquine consumption is better than" exact="chloroquine" post="(during long-term use) due to its fewer side effects."/>
 <result pre="severe disease classification Critical Critical Critical Critical Critical Treatments â€ƒSteroids" exact="Methylprednisolone" post="Methylprednisolone Methylprednisolone Methylprednisolone Methylprednisolone â€ƒAntivirals Lopinavir/ritonavir; Interferon alfa-1b; favipiravir"/>
 <result pre="disease classification Critical Critical Critical Critical Critical Treatments â€ƒSteroids Methylprednisolone" exact="Methylprednisolone" post="Methylprednisolone Methylprednisolone Methylprednisolone â€ƒAntivirals Lopinavir/ritonavir; Interferon alfa-1b; favipiravir Lopinavir/ritonavir;"/>
 <result pre="classification Critical Critical Critical Critical Critical Treatments â€ƒSteroids Methylprednisolone Methylprednisolone" exact="Methylprednisolone" post="Methylprednisolone Methylprednisolone â€ƒAntivirals Lopinavir/ritonavir; Interferon alfa-1b; favipiravir Lopinavir/ritonavir; Arbidol;"/>
 <result pre="Critical Critical Critical Critical Critical Treatments â€ƒSteroids Methylprednisolone Methylprednisolone Methylprednisolone" exact="Methylprednisolone" post="Methylprednisolone â€ƒAntivirals Lopinavir/ritonavir; Interferon alfa-1b; favipiravir Lopinavir/ritonavir; Arbidol; darunavir"/>
 <result pre="Critical Critical Critical Critical Treatments â€ƒSteroids Methylprednisolone Methylprednisolone Methylprednisolone Methylprednisolone" exact="Methylprednisolone" post="â€ƒAntivirals Lopinavir/ritonavir; Interferon alfa-1b; favipiravir Lopinavir/ritonavir; Arbidol; darunavir Lopinavir/ritonavir;"/>
 <result pre="that in cell culture soluble ACE2 fused to Ig or" exact="camostat" post="mesylate which is a nonspecific protease inhibitor can inhibit"/>
 <result pre="Pseudovirus bearing the S protein of SARS-CoV-2. High doses of" exact="camostat" post="mesylate were indicated to partially reduce SARS-CoV-2 growth [123]."/>
 <result pre="Ribonucleic Acid DNA Deoxyribonucleic Acid WHO World Health Organization CQ" exact="Chloroquine" post="MOI Multiplicity of Infection EC50 half-maximal Effective Concentration CC50"/>
 <result pre="of Infection EC50 half-maximal Effective Concentration CC50 Half-Cytotoxic Concentration HCQ" exact="Hydroxychloroquine" post="HIV Human Immunodeficiency Viruses RAAS Renin-Angiotensin-Aldosterone System AT1R Angiotensin"/>
 <result pre="version)Military Med Res2020714 34.Gao J, Tian Z, Yang X. Breakthrough:" exact="Chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="2 and its inhibition by the antimalarial quinolinesBiochemistry200443154538454715078100 49.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="2010 Jan 1;69(01):20â€&quot;8.doi: 10.1136/ard.2008.101766. 54.Fox RI. Mechanism of action of" exact="hydroxychloroquine" post="as an antirheumatic drug. In Seminars in arthritis and"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
 <result pre="activity of the IMP dehydrogenase inhibitor VX-497: a comparison with" exact="ribavirin" post="and demonstration of antiviral additivity with alpha interferon. Antimicrob"/>
 <result pre="a comparison with ribavirin and demonstration of antiviral additivity with" exact="alpha" post="interferon. Antimicrob Agents Chemother. 2000;44(4):859â€&quot;66. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89783/. 64.KimUJWonEJKeeSJJungSIJangHCCase report combination"/>
 <result pre="Agents Chemother. 2000;44(4):859â€&quot;66. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89783/. 64.KimUJWonEJKeeSJJungSIJangHCCase report combination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferon-Î± for Middle East respiratory syndromeAntivir Ther20162145545910.3851/IMP300226492219 65.ZeinalianMSalari-JaziAJannesariAKhanahmadHA"/>
 <result pre="preprint arXiv:2003.00751. 2020 Mar 2.doi: 10.1159/000508278. 71.Frie K, Gbinigie K." exact="Chloroquine" post="and hydroxychloroquine: current evidence for their effectiveness in treating"/>
 <result pre="X. Molecular modeling evaluation of the binding effect of ritonavir," exact="lopinavir" post="and darunavir to severe acute respiratory syndrome coronavirus 2"/>
 <result pre="with severe 2009 influenza A (H1N1) infectionChest2013144246447323450336 78.Day M. Covid-19:" exact="ibuprofen" post="should not be used for managing symptoms, say doctors"/>
 <result pre="Courjon J, Giordanengo V, Vieira VE, Dupont HT, HonorÃ© S." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVID-19: results of"/>
 <result pre="Giordanengo V, Vieira VE, Dupont HT, HonorÃ© S. Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="20:105949.doi: 10.1016/j.ijantimicag.2020.105949. 89.SooYOChengYWongRHuiDSLeeCKTsangKKNgMHChanPChengGSungJJRetrospective comparison of convalescent plasma with continuing high-dose" exact="methylprednisolone" post="treatment in SARS patientsClin Microbiol Infect200410767667815214887 90.LaiSTTreatment of severe"/>
</results>
